BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8538036)

  • 1. [Hereditary hematopoietic malignancy with emphasis of juvenile chronic myelogenous leukemia and 7 monosomy syndrome].
    Hayashi Y
    Nihon Rinsho; 1995 Nov; 53(11):2737-41. PubMed ID: 8538036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome pattern in juvenile chronic myelogenous leukemia, myelodysplastic syndrome, and acute leukemia associated with neurofibromatosis.
    Kaneko Y; Maseki N; Sakurai M; Shibuya A; Shinohara T; Fujimoto T; Kanno H; Nishikawa A
    Leukemia; 1989 Jan; 3(1):36-41. PubMed ID: 2491896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monosomy 7 myeloproliferative disease in children with neurofibromatosis, type 1: epidemiology and molecular analysis.
    Shannon KM; Watterson J; Johnson P; O'Connell P; Lange B; Shah N; Steinherz P; Kan YW; Priest JR
    Blood; 1992 Mar; 79(5):1311-8. PubMed ID: 1536955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders.
    Shannon KM; O'Connell P; Martin GA; Paderanga D; Olson K; Dinndorf P; McCormick F
    N Engl J Med; 1994 Mar; 330(9):597-601. PubMed ID: 8302341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis.
    Zvulunov A; Barak Y; Metzker A
    Arch Dermatol; 1995 Aug; 131(8):904-8. PubMed ID: 7632061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monosomy 7 myeloproliferative disease associated with neurofibromatosis type I: a case report.
    Savasan S; Zülfikar B; Ozgeneci A; Ozbek U; Sengün Z
    J Chemother; 1996 Jun; 8(3):243-6. PubMed ID: 8808725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1.
    Maris JM; Wiersma SR; Mahgoub N; Thompson P; Geyer RJ; Hurwitz CG; Lange BJ; Shannon KM
    Cancer; 1997 Apr; 79(7):1438-46. PubMed ID: 9083167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelodysplastic syndromes: the pediatric point of view.
    Locatelli F; Zecca M; Pession A; Maserati E; De Stefano P; Severi F
    Haematologica; 1995; 80(3):268-79. PubMed ID: 7672722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood myeloproliferative disorders.
    Cotter FE
    Baillieres Clin Haematol; 1998 Dec; 11(4):875-98. PubMed ID: 10640222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutation as the second event in juvenile chronic myelogenous leukemia in a patient with neurofibromatosis type 1.
    Luria D; Avigad S; Cohen IJ; Stark B; Weitz R; Zaizov R
    Cancer; 1997 Nov; 80(10):2013-8. PubMed ID: 9366306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular evidence that childhood monosomy 7 syndrome is distinct from juvenile chronic myelogenous leukemia and other childhood myeloproliferative disorders.
    Butcher M; Frenck R; Emperor J; Paderanga D; Maybee D; Olson K; Shannon K
    Genes Chromosomes Cancer; 1995 Jan; 12(1):50-7. PubMed ID: 7534111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A chronic myeloid leukemia-like syndrome case with del (12) (p12) in a Li-Fraumeni syndrome family.
    Guran S; Beyan C; Nevruz O; Yakicier C; Tunca Y
    Clin Lab Haematol; 2005 Apr; 27(2):135-8. PubMed ID: 15784129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity of NF1 gene in juvenile chronic myelogenous leukemia with neurofibromatosis type 1.
    Kai S; Sumita H; Fujioka K; Takahashi H; Hanzawa N; Funabiki T; Ikuta K; Sasaki H
    Int J Hematol; 1998 Jul; 68(1):53-60. PubMed ID: 9713168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile chronic myelogenous leukemia, neurofibromatosis 1, and xanthoma.
    Jang KA; Choi JH; Sung KJ; Moon KC; Koh JK; Im DJ
    J Dermatol; 1999 Jan; 26(1):33-5. PubMed ID: 10063210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monosomy 7 syndrome in an infant with neurofibromatosis.
    Kelleher JF; Carbone TV
    Am J Pediatr Hematol Oncol; 1991; 13(3):338-41. PubMed ID: 1793161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin, blood, nerve cells, and heritability. New lessons from neurofibromatosis type 1.
    Riccardi VM
    Arch Dermatol; 1995 Aug; 131(8):944. PubMed ID: 7632067
    [No Abstract]   [Full Text] [Related]  

  • 17. [Detection of trisomy 8 and monosomy 7 in chronic granulocytic leukemia and myelodysplastic syndrome by cytogenetic analysis and fluorescence in situ hybridization].
    Szabó Gabriella P; Balogh E; Jakab Z; Germán P; Bodnár F; Kiss A; Telek B; Oláh E
    Orv Hetil; 2002 Dec; 143(50):2775-9. PubMed ID: 12583317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: two cases with a different outcome.
    Navarro JT; Feliu E; Grau J; Espinet B; Colomer D; Ribera JM; Oriol A; Granada I; Juncà J; Millá F
    Am J Hematol; 2007 Sep; 82(9):849-51. PubMed ID: 17563075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of the N-ras gene in juvenile chronic myelogenous leukemia.
    Miyauchi J; Asada M; Sasaki M; Tsunematsu Y; Kojima S; Mizutani S
    Blood; 1994 Apr; 83(8):2248-54. PubMed ID: 8161790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of neurofibromatosis type 1 gene mutation in juvenile chronic myelogenous leukemia.
    Watanabe I; Horiuchi T; Hatta N; Matsumoto M; Koike K; Kojima S; Ohga S; Fujita S
    Acta Haematol; 1998; 100(1):22-5. PubMed ID: 9691142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.